Effect of Smoking and Time of Day on Eosinophils in Healthy Adults
Official title: Effects of Acute Smoking and Time of Day on Blood Eosinophils in Humans
Run by University of Rostock · NCT07625111 · Data updated 2026-11-12
This study tests how acute smoking and the time of day affect blood eosinophil levels in healthy adults who smoke compared with non-smokers.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of Rostock Academic / other |
| Locations | 1 site (Rostock) |
| Status | Recruiting |
| Started | February 7, 2026 |
| Main results expected | June 30, 2026 |
| Study ends | December 6, 2026 |
| Registry record updated | June 4, 2026 |
| Trial ID | NCT07625111 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-50 who currently smoke at least 8 cigarettes per day and have no chronic respiratory diseases.
✕Probably not a fit
Individuals with chronic respiratory diseases or recent corticosteroid or immunosuppressant use may not see benefit or may be excluded for safety and data integrity.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this cross-over/interventional study, researchers compare blood eosinophil counts and surface markers in 20 chronic smokers and 20 never-smokers. Each smoker undergoes two 4-hour sessions between 8 am and 12 pm: one with no smoking between 8 and 12 am and another after smoking 8 cigarettes, with sessions at least four weeks apart. Blood samples are collected at 8 am and 12 pm in both groups, and analyses include flow cytometry of eosinophil surface molecules, lung function tests, exhaled nitric oxide, and serum IgE. The aim is to see how time of day and acute smoking influence eosinophils and related immune markers in otherwise healthy adults without chronic respiratory disease.
Why it matters
Potential benefit: If successful, the findings could clarify how smoking and daily timing influence eosinophil-related immune responses in healthy people.
How similar studies have gone: Previous work has explored temporal and smoking-related changes in eosinophils, but this exact cross-over design in healthy adults is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy current smokers * Age between 18-50 years * Smoking of at least 8 cigarettes/day Exclusion Criteria: * Chronic respiratory diseases * Any treatment with corticosteroids or other immunosuppressants * Any acute illness
Where it's running
-
University of Rostock
Rostock, Germany Recruiting
Study contacts
- Study coordinator: Marek Prof. Lommatzsch, Prof.
- Email: marek.lommatzsch@med.uni-rostock.de
- Phone: +49-381-494-7461
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?
This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
-
Miricell supplementation and markers of healthy aging
This trial tests whether taking Miricell once daily for 12 weeks improves cellular health and brain/metabolic indicators in adults aged 40–70 compared with a placebo.
-
Does daily lean beef support brain health in older adults
In healthy adults aged 65 and up, this study tests whether eating lean beef every day for two weeks can influence brain health markers compared with a non-beef, protein-matched option.
-
Adaptive computerized training to boost thinking in healthy seniors and those with mild cognitive impairment
This study tests whether a computer-based training program can improve executive thinking in older adults, including those with mild cognitive impairment, and see if it also helps memory and well-being.
-
SHARP: Personalized Health and Behavior Plan to Lower Biological Age in Older Adults
A 12-month randomized trial tests whether a personalized health and behavior program can lower biological age and improve function in healthy adults over 50.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.